Law360, New York (October 27, 2009, 5:30 PM ET) -- Hoffmann-La Roche Inc. has won the reversal of a $7 million jury verdict in favor of a man who claimed he developed inflammatory bowel disease after taking the drugmaker's acne medication Accutane.
A Florida appeals court issued a per curiam order overturning the award on Tuesday, saying plaintiff Adam Mason had presented no evidence at his trial to support the claim that Accutane's deficient warning label was the proximate cause of his disease.
The Nutley, N.J.-based unit of Swiss pharmaceutical giant Roche Holding AG appealed the...
Roche Wins Reversal Of $7M Accutane Verdict
To view the full article, take a free trial now.
